Operating Income: The income after operating expenses.
Vaxcyte, Inc. (PCVX) had Operating Income of $-226.22M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-166.57M |
|
-- |
|
-- |
|
$226.22M |
|
|
Operating Income |
$-226.22M |
$59.65M |
|
$-166.57M |
|
$-166.57M |
|
$-166.57M |
|
$-166.57M |
|
$-166.57M |
|
$-166.57M |
|
$-226.22M |
|
$-225.72M |
|
136.03M |
|
136.03M |
|
$-1.22 |
|
$-1.22 |
|
| Balance Sheet Financials | |
$1.72B |
|
$242.27M |
|
$1.59B |
|
$3.31B |
|
$154.49M |
|
-- |
|
$79.54M |
|
$234.03M |
|
$3.07B |
|
$3.07B |
|
$3.07B |
|
129.82M |
|
| Cash Flow Statement Financials | |
$-287.44M |
|
$201.06M |
|
$3.28M |
|
$389.19M |
|
$308.06M |
|
$-81.13M |
|
$67.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-294.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.42% |
|
-5.42% |
|
-5.04% |
|
-5.42% |
|
$23.66 |
|
$-2.17 |
|
$-2.11 |
|